Mettler-Toledo International (NYSE:MTD) Given New $1,400.00 Price Target at Citigroup

Mettler-Toledo International (NYSE:MTD) had its price target trimmed by Citigroup from $1,450.00 to $1,400.00 in a research report sent to investors on Tuesday morning,Benzinga reports. The brokerage currently has a neutral rating on the medical instruments supplier’s stock.

Several other brokerages also recently issued reports on MTD. Evercore ISI boosted their price objective on Mettler-Toledo International from $1,450.00 to $1,475.00 and gave the stock an “outperform” rating in a research report on Monday, February 10th. Wells Fargo & Company boosted their price objective on Mettler-Toledo International from $1,350.00 to $1,400.00 and gave the stock an “equal weight” rating in a research report on Monday, February 10th. Robert W. Baird boosted their price objective on Mettler-Toledo International from $1,362.00 to $1,369.00 and gave the stock a “neutral” rating in a research report on Monday, February 10th. Stifel Nicolaus reduced their price objective on Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating for the company in a research report on Monday, November 11th. Finally, Wolfe Research began coverage on Mettler-Toledo International in a research report on Friday, December 13th. They set a “peer perform” rating for the company. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and three have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Mettler-Toledo International currently has a consensus rating of “Hold” and an average target price of $1,380.50.

Mettler-Toledo International Trading Down 2.1 %

NYSE:MTD opened at $1,242.44 on Tuesday. The firm has a market capitalization of $25.99 billion, a PE ratio of 30.65, a price-to-earnings-growth ratio of 3.30 and a beta of 1.13. The stock has a 50 day moving average of $1,291.82 and a 200-day moving average of $1,326.68. Mettler-Toledo International has a 52 week low of $1,142.91 and a 52 week high of $1,546.93.

Mettler-Toledo International (NYSE:MTD) last posted its earnings results on Thursday, February 13th. The medical instruments supplier reported $12.41 EPS for the quarter, beating the consensus estimate of $11.76 by $0.65. Mettler-Toledo International had a negative return on equity of 591.54% and a net margin of 22.29%. As a group, analysts predict that Mettler-Toledo International will post 42.71 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, insider Christian Magloth sold 790 shares of the stock in a transaction on Monday, February 24th. The stock was sold at an average price of $1,313.69, for a total transaction of $1,037,815.10. Following the completion of the sale, the insider now owns 734 shares in the company, valued at approximately $964,248.46. This represents a 51.84 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Gerry Keller sold 600 shares of the stock in a transaction on Monday, February 10th. The shares were sold at an average price of $1,351.34, for a total value of $810,804.00. Following the sale, the insider now owns 6 shares of the company’s stock, valued at $8,108.04. This trade represents a 99.01 % decrease in their position. The disclosure for this sale can be found here. 1.94% of the stock is currently owned by insiders.

Institutional Trading of Mettler-Toledo International

Hedge funds have recently modified their holdings of the business. Ashton Thomas Securities LLC purchased a new stake in shares of Mettler-Toledo International in the third quarter valued at $37,000. SBI Securities Co. Ltd. purchased a new stake in shares of Mettler-Toledo International in the fourth quarter valued at $33,000. Edmond DE Rothschild Holding S.A. purchased a new stake in shares of Mettler-Toledo International in the fourth quarter valued at $44,000. Blue Trust Inc. lifted its holdings in shares of Mettler-Toledo International by 70.8% in the fourth quarter. Blue Trust Inc. now owns 41 shares of the medical instruments supplier’s stock valued at $50,000 after purchasing an additional 17 shares in the last quarter. Finally, Whipplewood Advisors LLC purchased a new stake in shares of Mettler-Toledo International in the fourth quarter valued at $54,000. Hedge funds and other institutional investors own 95.07% of the company’s stock.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.